WAYNE, Pa. (AP) _ Aclaris Therapeutics Inc. (ACRS) on Friday reported a loss of $31.2 million in its second quarter.

The Wayne, Pennsylvania-based company said it had a loss of $1.01 per share.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 95 cents per share.

The specialty pharmaceutical company posted revenue of $3.7 million in the period, beating Street forecasts. Three analysts surveyed by Zacks expected $2.8 million.

Aclaris shares have declined 27 percent since the beginning of the year. The stock has declined 35 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACRS at https://www.zacks.com/ap/ACRS